GVCAX
Price
$10.39
Change
+$0.01 (+0.10%)
Updated
May 8 closing price
Net Assets
207.03M
VMVAX
Price
$82.33
Change
+$0.60 (+0.73%)
Updated
May 8 closing price
Net Assets
29.07B
Ad is loading...

GVCAX vs VMVAX

Header iconGVCAX vs VMVAX Comparison
Open Charts GVCAX vs VMVAXBanner chart's image
Gabelli Value 25 AAA
Price$10.39
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets207.03M
Vanguard Mid-Cap Value Index Admiral
Price$82.33
Change+$0.60 (+0.73%)
VolumeN/A
Net Assets29.07B
GVCAX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVCAX vs. VMVAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVCAX is a Buy and VMVAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVAX has more cash in the bank: 29.1B vs. GVCAX (207M). VMVAX pays higher dividends than GVCAX: VMVAX (2.40) vs GVCAX (0.53). GVCAX was incepted earlier than VMVAX: GVCAX (15 years) vs VMVAX (14 years). GVCAX (1.49) is less costly to investors than VMVAX (0.07). VMVAX is a more actively managed with annual turnover of: 19.00 vs. GVCAX (5.00). GVCAX has a lower initial minimum investment than VMVAX: GVCAX (1000) vs VMVAX (3000). GVCAX annual gain was more profitable for investors over the last year : 5.11 vs. VMVAX (3.70). VMVAX return over 5 years is better than : 75.12 vs. GVCAX (-4.06).
GVCAXVMVAXGVCAX / VMVAX
Total Expense Ratio1.490.072,129%
Annual Report Gross Expense Ratio1.490.072,129%
Fund Existence15 years14 years-
Gain YTD5.274-2.399-220%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets207M29.1B1%
Annual Yield % from dividends0.532.4022%
Returns for 1 year5.113.70138%
Returns for 3 years-11.2214.12-79%
Returns for 5 years-4.0675.12-5%
Returns for 10 years-42.3973.65-58%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBDO2.400.30
+14.29%
Banco Bradesco SA
GLUE4.220.37
+9.61%
Monte Rosa Therapeutics
GRC37.751.07
+2.92%
Gorman-Rupp Company (The)
SNDR23.030.63
+2.81%
Schneider National
KALA3.43-0.02
-0.58%
Kala BIO